Category
Primary
pharmaceutical-drugs · embed-ft 0.28
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
AI readiness
Compliance (GEO / GDPR)
TLD
Overview
Title
TAKHZYRO® (lanadelumab-flyo) | Treatment
Description
TAKHZYRO is a prescription medicine used to prevent hereditary angioedema (HAE) attacks in patients 2 years and older. See Safety and Allergic Reaction Information.
Final URL
Language
en (content)
Scanned at
2026-06-27 14:58:47